Please assess the completion status of the following clinical trial:

Trial Title: Investigation of the Ability of the TENA SmartCare Change Indicator to Reduce the Number of Manual Checks Between Changes of Absorbing Incontinence Products

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. DEU is diagnosed with urinary incontinence managed with a tape-style incontinence product.~2. DEU is unable to sufficiently communicate the need for an incontinence product to be changed.~3. DEU is being cared for in a home environment and most of the care is provided by a main CGR.~4. DEU is willing and able to provide informed consent and to participate in the clinical investigation or has a legally designated representative willing to provide informed consent on behalf of the DEU. Note, the legally designated representative and main CGR cannot be the same person.~5. CGR is willing and able to provide informed consent to participate in the clinical investigation.~6. The CGR frequently checks the saturation level of the incontinence product, manually and/or by a touch-feel process.~7. If incontinence is managed by pharmaceuticals, the dose regime is stable.~8. DEU and CGR ≥ 18 years of age.~Exclusion Criteria:~1. DEU is cared for in a professional establishment or is institutionalized.~2. DEU has ≥ 4 fecal incidences per week.~3. DEU has severe incontinence product related skin problems, as judged by the investigator.~4. DEU has any type of urinary catheter(s) resulting in improved/treated urinary incontinence.~5. The incontinence product is changed on a routine based on time (schedule) or device alert, without manual checks.~6. Any other condition that may make participation in the clinical investigation inappropriate, as judged by investigator.~7. CGR is incapable or unwilling to use the required smart phone application and/or the diary registration webpage required for the clinical investigation.~8. Participation in an investigational study of a drug, biologic, or device within 30 days prior to entering the clinical investigation or planned during the course of the clinical investigation.~9. DEU is pregnant or nursing.~10. CGR or DEU with an alcohol or drug addiction

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Investigational Device (Type: EXPERIMENTAL): TENA SmartCare Change Indicator

Based on this trial design, predict the completion outcome and termination type (if applicable).